|
1
|
Koo JS, Jung W and Jeong J: Metastatic
breast cancer shows different immunohistochemical phenotype
according to metastatic site. Tumori. 96:424–432. 2010.PubMed/NCBI
|
|
2
|
Apffelstaedt JP, Van Zyl JA and Muller AG:
Breast cancer complicated by pleural effusion: Patient
characteristics and results of surgical management. J Surg Oncol.
58:173–175. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Evans TRJ, Stein RC, Pepper JR, Gazet JC,
Ford HT and Coombes RC: A randomized prospective trial of surgical
against medical tetracycline pleurodesis in the management of
malignant pleural effusions secondary to breast-cancer. Eur J
Cancer. 29A:316–319. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Posner MR, Cohen GI and Skarin AT:
Pericardial disease in patients with cancer. The differentiation of
malignant from idiopathic and radiation-induced pericarditis. Am J
Med. 71:407–413. 1981. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Levitan Z, Kaplan AL and Gordon AN:
Survival after malignant pericardial effusion and cardiac tamponade
in advanced ovarian cancer. South Med J. 83:241–242. 1990.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Shetty J, Prasad K, Rao M and Nayak A:
Isolated leptomeningeal metastases originating from infiltrating
ductal carcinoma of breast - A case report. IJRRMS. 2:2012.
|
|
7
|
Jemal A, Siegel R, Ward E, Hao Y, Xu J,
Murray T and Thun MJ: Cancer statistics, 2008. CA Cancer J Clin.
58:71–96. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Largillier R, Ferrero JM, Doyen J,
Barriere J, Namer M, Mari V, Courdi A, Hannoun-Levi JM, Ettore F
and Birtwisle-Peyrottes I: Prognostic factors in 1,038 women with
metastatic breast cancer. Ann Oncol. 19:2012–2019. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Bruna J, Simó M and Velasco R:
Leptomeningeal metastases. Curr Treat Options Neurol. 14:402–415.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ugenskiené R and Juozaityté E: The
molecular mechanisms of breast cancer metastasis. Biologija.
58:2012.
|
|
11
|
Hortobagyi GN: Can we cure limited
metastatic breast cancer? J Clin Oncol. 20:620–623. 2002.PubMed/NCBI
|
|
12
|
Greenberg PA, Hortobagyi GN, Smith TL,
Ziegler LD, Frye DK and Buzdar AU: Long-term follow-up of patients
with complete remission following combination chemotherapy for
metastatic breast cancer. J Clin Oncol. 14:2197–2205.
1996.PubMed/NCBI
|
|
13
|
Dawood S, Broglio K, Ensor J, Hortobagyi
GN and Giordano SH: Survival differences among women with de novo
stage IV and relapsed breast cancer. Ann Oncol. 21:2169–2174. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Güth U, Magaton I, Huang DJ, Fisher R,
Schötzau A and Vetter M: Primary and secondary distant metastatic
breast cancer: Two sides of the same coin. Breast. 23:26–32. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Weigelt B, Peterse JL and van't Veer LJ:
Breast cancer metastasis: Markers and models. Nat Rev Cancer.
5:591–602. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
16
|
Solomayer EF, Diel IJ, Meyberg GC, Gollan
C and Bastert G: Metastatic breast cancer: Clinical course,
prognosis and therapy related to the first site of metastasis.
Breast Cancer Res Treat. 59:271–278. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Cutler SJ, Ardyce JA and Taylor SG III:
Classification of patients with disseminated cancer of the breast.
Cancer. 24:861–869. 1969. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Fentiman IS, Millis R, Sexton S and
Hayward JL: Pleural effusion in breast cancer: A review of 105
cases. Cancer. 47:2087–2092. 1981. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Dieterich M, Goodman SN, Rojas-Corona RR,
Emralino AB, Jimenez-Joseph D and Sherman ME: Multivariate analysis
of prognostic features in malignant pleural effusions from breast
cancer patients. Acta Cytol. 38:945–952. 1994.PubMed/NCBI
|
|
20
|
Hirata T, Yonemori K, Hirakawa A, Shimizu
C, Tamura K, Ando M, Katsumata N, Tanimoto M and Fujiwara Y:
Efficacy of pleurodesis for malignant pleural effusions in breast
cancer patients. Eur Respir J. 38:1425–1430. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Stitt VJ Jr: Breast carcinoma with
pericardial metastasis. J Natl Med Assoc. 79:195–197.
1987.PubMed/NCBI
|
|
22
|
Scott BJ and Kesari S: Leptomeningeal
metastases in breast cancer. Am J Cancer Res. 3:117–126.
2013.PubMed/NCBI
|
|
23
|
Rodríguez-Pinilla SM, Sarrió D, Honrado E,
Hardisson D, Calero F, Benitez J and Palacios J: Prognostic
significance of basal-like phenotype and fascin expression in
node-negative invasive breast carcinomas. Clin Cancer Res.
12:1533–1539. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Chang BW, Decker RH, Haffty BG and Knisely
JPS: Incidence of brain metastases in early-stage triple negative
breast cancer patients. Int J Radiat Oncol Biol Phys. 69(Suppl):
S210–S211. 2007. View Article : Google Scholar
|
|
25
|
Lin Y, Yin W, Yan T, Zhou L, Di G, Wu J,
Shen Z, Shao Z and Lu J: Site-specific relapse pattern of the
triple negative tumors in Chinese breast cancer patients. BMC
Cancer. 9:3422009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Lee SS, Ahn JH, Kim MK, Sym SJ, Gong G,
Ahn SD, Kim SB and Kim WK: Brain metastases in breast cancer:
Prognostic factors and management. Breast Cancer Res Treat.
111:523–530. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Santos GT, Prolla JC, Camillo ND, Zavalhia
LS, Ranzi AD and Bica CG: Clinical and pathological factors
influencing the survival of breast cancer patients with malignant
pleural effusion. J Bras Pneumol. 38:487–493. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Chang EL and Lo S: Diagnosis and
management of central nervous system metastases from breast cancer.
Oncologist. 8:398–410. 2003. View Article : Google Scholar : PubMed/NCBI
|
